Together these observations indicate that KLF2 regulates programs that supress inflammatory activation and the absence of KLF2 in macrophages leads to greater antibacterial properties but also increases the unwanted side-effects of unrestrained inflammatory activation, as seen in sepsis. The gene discussed is KLF2; the disease is Sepsis.